Selected article for: "activity specificity and low specificity"

Author: Zhang, Qi-Yu; Yan, Zhi-Bin; Meng, Yue-Ming; Hong, Xiang-Yu; Shao, Gang; Ma, Jun-Jie; Cheng, Xu-Rui; Liu, Jun; Kang, Jian; Fu, Cai-Yun
Title: Antimicrobial peptides: mechanism of action, activity and clinical potential
  • Cord-id: pn1qd6bb
  • Document date: 2021_9_9
  • ID: pn1qd6bb
    Snippet: The management of bacterial infections is becoming a major clinical challenge due to the rapid evolution of antibiotic resistant bacteria. As an excellent candidate to overcome antibiotic resistance, antimicrobial peptides (AMPs) that are produced from the synthetic and natural sources demonstrate a broad-spectrum antimicrobial activity with the high specificity and low toxicity. These peptides possess distinctive structures and functions by employing sophisticated mechanisms of action. This com
    Document: The management of bacterial infections is becoming a major clinical challenge due to the rapid evolution of antibiotic resistant bacteria. As an excellent candidate to overcome antibiotic resistance, antimicrobial peptides (AMPs) that are produced from the synthetic and natural sources demonstrate a broad-spectrum antimicrobial activity with the high specificity and low toxicity. These peptides possess distinctive structures and functions by employing sophisticated mechanisms of action. This comprehensive review provides a broad overview of AMPs from the origin, structural characteristics, mechanisms of action, biological activities to clinical applications. We finally discuss the strategies to optimize and develop AMP-based treatment as the potential antimicrobial and anticancer therapeutics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40779-021-00343-2.

    Search related documents:
    Co phrase search for related documents
    • adaptive immune response and liver kidney: 1, 2
    • adaptive immune response and long term inflammation: 1
    • adaptive immune response and low expression: 1, 2
    • adaptive immune response and lps lipopolysaccharide: 1
    • adaptive immune response and lung cancer: 1
    • adaptive immune response and lymphocyte granulocyte: 1
    • adaptive immune response and machine learning: 1, 2, 3, 4, 5, 6
    • adaptive immune response and macrophage inflammatory: 1
    • additional file and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • additional file and low similarity: 1
    • additional file and macrophage neutrophil: 1
    • liver kidney and long term exposure: 1, 2
    • liver kidney and low concentration: 1, 2, 3
    • liver kidney and low expression: 1, 2, 3
    • liver kidney and low toxicity: 1, 2
    • liver kidney and machine learning: 1, 2